DISPATCHES FROM INTERPHEX

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Loading the player...

Over the last decade single-use technologies have moved into manufacturing scales and are increasingly being deployed worldwide, according to Thermo Fisher Scientific.

In-Pharmatechnologist.com caught up with Thermo Fisher at this year’s Interphex in New York City. The company, along with showcasing its new Aegis 514 film, spoke with us about the evolution of single-use technology in upstreaming processing.

“Over the last 3-5 years bioreactors have moved into manufacturing scales,” said Director of Global Marketing, Cell Culture and Bioprocessing, Brandon Pence. “Improvements in single-use technology with improvements in media design now makes a 2,000l single-use bioreactor the equivalent of a 10,000l traditional bioreactor a decade ago.”

VP and General Manager of the unit, Cory Stevenson, also spoke of how Thermo Fisher’s Aegis 514 was an evolution of the company’s CX514 film – released ten years ago and the industry’s first animal component free film dedicated to bioprocessing applications.

Future Stance and Life Technologies

Stevenson told us the company is “uniquely positioned with a number of different solutions” and services for its customers in biopharma production in the next year, including analytics, clinical testing and cell-banking services.

One area not discussed was Thermo Fisher’s $13.6bn purchase of Life Technologies last month.

Discussing Q1 2013 results, Marc Casper, Thermo Fisher’s CEO, said the acquisition will push the company to become an “unrivaled leader,” establishing technology and innovation leadership across key life sciences markets.

The transaction will be completed in early 2014.

Related News

New DPM plant opens in Singapore

Thermo Fisher Opens First Dry Powder Media Plant in Singapore

Must Know BioPharma News

Technology News Is Vital for BioPharmas MIT Prof Tells BioPharma-Reporter.com

Thermo Fisher awaits monopoly commissions decisions on $13.6bn Life Tech acquisition

Thermo Fisher awaits regulatory nod for Life Tech acquisition

Thermo Fisher must divest certain businesses, according to the EC

Thermo Fisher to divest HyClone cell culture biz following Life Tech approval

HyClone units to keep Utah and Colorado HQs says GE

HyClone units to keep Utah and Colorado HQs says GE Healthcare

China antitrust agency insists Thermo Fisher cuts prices

China OKs $13bn Life Tech takeover but insists on Thermo price cuts

Life Technology acquisition coming together, with Thermo Fisher predicting February approval

Thermo Fisher: 'Life begins in February,' as it awaits FTC approval

Thermo Fisher is at “the end of the first quarter with three quarters to go,” CEO Marc Casper said describing potential growth in biopharma services

Thermo Fisher raises guidance on 'fabulous' biopharma services growth

Single-use industry continues to consolidate as Thermo Fisher buys ASI

Thermo Fisher buys ASI but will consolidation drive innovation in single-use?

Image: iStock/Jürgen François

Thermo Fisher: ‘Biopharma’s drive for efficiency plays into our sweet spot’

Image: iStock/albertobrian

GE on film: Reducing risk of leachables starts with the raw materials

Thermo fishe's for pharma mol bio business in Eastern Europe

Thermo Fisher targets Eastern Europe’s pharmas with new R&D site

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

Thermo Fisher Acquires Life Tech for $13.6B

Thermo Fisher Acquires Life Tech for $13.6B

Single use tech for biopharma: Pall and Thermo Fisher

The quest for more understanding is behind the single use boom: Pall and Thermo Fisher

Thermo adds control system to cut bioreactor setup times

Related Products

See more related products